The CIBACALCIN brand, founded in 1974 (Switzerland), from 2951 sister brands and 17477 competing brands. CIBACALCIN is owned by NOVARTIS N, listed on the stock exchange of Zurich The International Securities Identification Number (ISIN) of NOVARTIS N is CH0012005267. CIBACALCIN belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
NOVARTIS N
(CIBACALCIN)
over 5 years*
CHF 103.21